Evidence map›Paper›PMID 39295906›Full record

ArticleGut microbiome (Cambridge, England)2023

White kidney bean extract as a nutraceutical: effects on gut microbiota, alpha-amylase inhibition, and user experiences.

David Houghton, Oliver M Shannon, Peter I Chater, Matthew D Wilcox, Jeffrey P Pearson, Kyle Stanforth, Cara Jordan, Leah Avery, Alasdair P Blain, Abraham Joel and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbiome (Cambridge, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Therapeutic Potential of White Kidney Beans (Foods (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

David HoughtonWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Oliver M ShannonHuman Nutrition and Exercise Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Peter I ChaterBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Matthew D WilcoxBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Jeffrey P PearsonBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Kyle StanforthBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Cara JordanSchool of Health and Life Sciences, Teesside University, Tees Valley, UK.
Leah AverySchool of Health and Life Sciences, Teesside University, Tees Valley, UK.
Alasdair P BlainWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Abraham JoelHuman Nutrition and Exercise Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Ruth JeffersSchool of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
Ruth NolanSchool of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
Andrew NelsonFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Christopher J StewartTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Fiona C MalcomsonHuman Nutrition and Exercise Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID https://orcid.org/0000-0001-5072-7644

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

White kidney bean extract (WKBE) is a nutraceutical often advocated as an anti-obesity agent. The main proposed mechanism for these effects is alpha-amylase inhibition, thereby slowing carbohydrate digestion and absorption. Thus, it is possible that WKBE could impact the gut microbiota and modulate gut health. We investigated the effects of supplementing 20 healthy adults with WKBE for 1 week in a randomised, placebo-controlled crossover trial on the composition of the gut microbiota, gastrointestinal (GI) inflammation (faecal calprotectin), GI symptoms, and stool habits. We conducted

Indexed as

Gut microbiotainflammationmodel gutwhite kidney beansα-amylase

Identifiers

PMID39295906
PMCPMC11406411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.